Camille L. Bedrosian, Chief Medical Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 10,028 shares at $32.21 ($325K) on 2026-09-10, disclosed to the SEC on 2026-09-14.
Open-market sale of $325k AMLX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.21 | 7,947 | $256K | 78.8% |
| 2 | $33.09 | 2,081 | $69K | 21.2% |
| Total | $32.40 avg | 10,028 | $325K | 100% |
| Filing → |
| AMLX | SELL | 2025-10-02 | $351K | — | Filing → |
| AMLX | SELL | 2025-04-02 | $43K | — | Filing → |
| AMLX | SELL | 2024-12-03 | $30K | — | Filing → |